Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations 
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half 
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit 
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation 
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat 
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 
World game at war: why some European nations have threatened a World Cup boycott 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
Japan Earthquake Disrupts Auto and Chip Supply Chains 
Same sparkle, different story: how lab-grown diamonds are transforming the market 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
BURLINGTON, Mass., April 18, 2018 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2018 financial results on Wednesday, April 25, 2018, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.
Access to the live call is available by dialing 844-239-5284 (+1-512-961-6497 for international callers), passcode 1197775. The call can also be accessed live or via replay through a webcast at www.lemaitre.com/investor.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc.
Steven Chehames
Investor Relations
+1-781-425-1659
[email protected]
http://www.lemaitre.com
LeMaitre Vascular, Inc.
